- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02796430
The ICALIC International Multicentric Study (ICALIC)
Clinical Evaluation of the Ease of Use of a New Indirect Calorimeter for Energy Expenditure Measurement in ICU Patients: The ICALIC International Multicentric Study
This study will evaluate the ease of use of the new calorimeter (Q-NRG (COSMED, Italy)) in intensive care unit (ICU) patients compared to currently used calorimeters (i.e. Quark RMR 1.0(COSMED, Italy) or Deltatrac Metabolic Monitor (Datex, Finland)), as well as the stability and the feasibility of the measurements in various clinically relevant situations.
Time needed to prepare and start indirect calorimetry (IC) measurement will be compared as the measure of the ease of use of the calorimeter.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background and Aims:
This study aims at evaluating the ease of use of the new calorimeter for the measurement of energy expenditure (EE) in intensive care unit (ICU) patients. EE in ICU patients is highly variable depending on the severity of the disease and treatments. Clinicians need to measure EE by indirect calorimetry (IC) to optimize nutritional support for the better clinical outcome. However, indirect calorimeters available on the market have insufficient accuracy for clinical and research use. Difficulties of handling and interpretation of results often limit IC in ICU patients. An accurate, easy-to-use calorimeter has been developed to meet these needs.
The Study Device:
The new calorimeter (Q-NRG, COSMED) is capable of IC measurements in mechanically ventilated patients without warm-up and limited calibration. The disposable in-line pneumotach flow meter and direct sampling of respiratory gas from the ventilator circuit enables the accurate measurement of oxygen consumption volume (VO2) and CO2 production volume (VCO2) to derive the energy expenditure. The software interface to manage the device and the collected data provides easy-to-use, user-friendly interface. Q-NRG does not bear the European Commission Conformity Mark (CE Mark), but has been approved by the Swiss authority for medical devices (Swissmedic) for use in this study. Q-NRG will be used in the way it is intended to be used as described in the instruction manual.
Currently used indirect calorimeters at each study center will be used as the comparator.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria
- Division of Cardiac Thoracic Vascular Anesthesia and Intensive Care Medicine
-
-
-
-
-
Brussels, Belgium
- Department of Intensive Care, Vrije Universiteit Brussel
-
-
-
-
-
Petah Tikva, Israel, 49100
- Critical Care Medicine, Institute for Nutrition Research, Rabin Medical Center, Beilison Hospital
-
-
-
-
-
Chiba, Japan
- Chiba University Hospital
-
-
-
-
-
Huddinge, Sweden
- Department of Anesthesiology and Intensive Care Medicine, Karolinska University Hospital
-
-
-
-
-
Geneva, Switzerland, 1211
- Service of Intensive Care, Geneva University Hospital
-
Lausanne, Switzerland, 1011
- Adult Intensive care, Lausanne University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Mechanically ventilated adult ICU patients
Exclusion Criteria:
- Fraction of inhaled oxygen (FIO2) > 70%
- Positive end expiratory pressure (PEEP) >10cmH2O
- Peak ventilatory pressure > 30cmH2O
- Presence of air leaks from thoracic drain tube
- Changes in vasoactive agent dose (>20%, <1 hr before and/or during IC)
- Agitation or change in sedative dose (>20%, <1 hr before and/or during IC)
- Change in body temperature (>0.5°C, <1 hr before and/or during IC)
- Expected duration of ICU stay < 24 hours
- Expected survival of the patient < 24 hours
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Mechanically ventilated patients
Ease of use will be assessed by analysing the time needed to start indirect calorimetry measurement, and results of indirect calorimetry measurements by both the new indirect calorimeter and the currently used calorimeters at each study center.
|
Comparison of the time needed to start EE measurements by the new calorimeter and the currently used calorimeter, including the time needed for calibration, patient data input, connection to the ventilator circuit.
Comparison of EE measurements by the new calorimeter and the currently used calorimeter when using different mechanical ventilators, different ventilation modes, different patient conditions and severity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time needed to start indirect calorimetry (IC) measurement in Q-NRG compared to currently used calorimeters
Time Frame: immediately after the measurement
|
Time from the start-up of the devices until the 1st recorded measurement will be measured and compared between Q-NRG and the currently used indirect calorimeters, including time needed for patient information input, warm-up and calibrations according to the instructions for the devices, and installation of the device components needed for the measurements on patients.
|
immediately after the measurement
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Comparison of energy expenditure(EE) from Q-NRG and currently used calorimeters
Time Frame: immediately after the measurement
|
EE measured by Q-NRG and currently used calorimeters will be compared to identify the differences of the characteristics of the measurements according to the different types of calorimeters.
|
immediately after the measurement
|
Coefficient of variation (CV) of EE for different mechanical ventilators
Time Frame: immediately after the measurement
|
CV of EE measured by Q-NRG when using different mechanical ventilators will be analyzed to evaluate the effects of the mechanical ventilators used during the indirect calorimetry measurement.
|
immediately after the measurement
|
CV of EE when using different ventilation modes
Time Frame: immediately after the measurement
|
CV of EE measured by Q-NRG when using different mechanical ventilation modes will be analyzed to evaluate the effect of different mechanical ventilation modes used during the indirect calorimetry measurement.
|
immediately after the measurement
|
CV of EE in various ranges of oxygen and airway pressure support
Time Frame: immediately after the measurement
|
CV of EE measured by the Q-NRG in different ranges of FiO2 will be analyzed to evaluate the difference in the stability of the measurements according to various FiO2 ranges.
|
immediately after the measurement
|
CV of EE when measured in different sedation/consciousness levels
Time Frame: immediately after the measurement
|
CV of EE measured by the Q-NRG in different levels of sedation/consciouness will be analyzed to evaluate the difference in the stability of the measurements according to various sedation/consciousness levels.
|
immediately after the measurement
|
CV of EE when measured in different levels of patient severity
Time Frame: immediately after the measurement
|
CV of EE measured by the Q-NRG in different levels of patient severity will be analyzed to evaluate the difference in the stability of the measurement according to various levels of severity.
|
immediately after the measurement
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Claude Pichard, MD, PhD, Clinical Nutrition, Geneva University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-137
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Boston Children's HospitalCompleted
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness PolyneuropathiesBrazil
-
Peking Union Medical College HospitalBaxter Healthcare CorporationUnknownNutrition Therapy for Critical Illness
-
Assistance Publique - Hôpitaux de ParisRecruitingCritical Illness Related Corticosteroids InsufficiencyFrance
-
Yuzuncu Yıl UniversityKahramanmaras Sutcu Imam University; Izmir Ataturk Training and Research HospitalCompleted
Clinical Trials on Time needed to start indirect calorimetry measurement
-
Rabin Medical CenterBaxter Healthcare CorporationUnknown
-
Evangelismos HospitalActive, not recruitingSurgery | Ulcerative ColitisGreece
-
Rabin Medical CenterCompleted
-
Paul EdwardsCompletedDecubitis UlcerUnited States
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompleted
-
University of EdinburghRoyal College of Surgeons of EdinburghCompletedLiver ResectionUnited Kingdom
-
IWK Health CentreActive, not recruiting
-
Université de MontréalFédération des producteurs acéricoles du QuébecCompletedAthletic Performance | Carbohydrate Ingestion | Fuel SelectionCanada
-
Hôpital Necker-Enfants MaladesUniversity Hospital, Strasbourg, France; Poitiers University Hospital; University... and other collaboratorsUnknownShock, Septic | Shock, HemorrhagicFrance
-
Memorial Sloan Kettering Cancer CenterPfizer; Dana-Farber Cancer Institute; University of Pittsburgh; University of VirginiaCompletedNeurofibromatosis | Meningioma | CNS Cancer | Hemangioblastoma | Intracranial HemangiopericytomaUnited States